Copyright
©The Author(s) 2020.
World J Stem Cells. Apr 26, 2020; 12(4): 277-287
Published online Apr 26, 2020. doi: 10.4252/wjsc.v12.i4.277
Published online Apr 26, 2020. doi: 10.4252/wjsc.v12.i4.277
Items | After transplantation | ||||
1 d | 15 d | 30 d | 45 d | 60 d | |
Negative control group | 36.67 ± 0.68 | 36.97 ± 0.32 | 37.45 ± 0.35 | 34.86 ± 0.43 | 38.13 ± 0.35 |
Model group | 23.19 ± 0.98 | 20.23 ± 0.49 | 18.30 ± 0.28 | 18.02 ± 0.41 | 17.25 ± 0.28 |
hUCMSC group | 21.19 ± 0.65 | 19.54 ± 0.27 | 21.77 ± 0.48 | 23.11 ± 0.38 | 24.28 ± 0.48 |
Positive control group | 22.50 ± 0.62 | 19.30 ± 0.37 | 24.53 ± 0.93 | 27.64 ± 0.34 | 28.06 ± 0.93 |
P value | P < 0.05 |
- Citation: Shen J, Cao D, Sun JL. Ability of human umbilical cord mesenchymal stem cells to repair chemotherapy-induced premature ovarian failure. World J Stem Cells 2020; 12(4): 277-287
- URL: https://www.wjgnet.com/1948-0210/full/v12/i4/277.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v12.i4.277